BioSpace News Archive

Nanoscope Therapeutics Inc. today announced that clinical development of its Multi-Characteristic Opsin (MCO) gene therapy platform will be featured in two presentations at the 22nd Euretina Congress, taking place September 1-4, 2022, in Hamburg, Germany and online.

Zimmer Biomet Holdings, Inc. today announced that members of the Executive Management Team will be presenting at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 10:30 a.m. Eastern Time and at the J.P. Morgan 13th Annual U.S. All Stars Conference.

Lyra Therapeutics, Inc. today announced that the company will present additional Phase 2 results from the LANTERN study for LYR‑210, the company’s lead product candidate for chronic rhinosinusitis, at the 68th Annual Meeting of the American Rhinologic Society (ARS), taking place September 9-10, 2022 in Philadelphia.

Bausch + Lomb Corporation, today announced that Joseph C. Papa, Sam Eldessouky and Arthur J. Shannon are scheduled to participate at the Wells Fargo 2022 Healthcare Conference in Boston on Sept. 7, 2022 1:55 p.m. ET and at the 20th Annual Morgan Stanley Global Healthcare Conference in New York on Sept. 13, 2022 at 10:00 a.m. ET.

Covalon Technologies Ltd. today announced its third quarter fiscal 2022 results.

Liminal BioSciences Inc. announced that Bruce Pritchard, Chief Executive Officer at Liminal BioSciences is scheduled to present a company overview on Wednesday 14th September at 09:30 a.m. (ET).

ZAP Surgical Systems, Inc. today announced that Denver-based Neurosurgery One became the first provider in the Rocky Mountain region to treat patients using the ZAP-X ® Gyroscopic Radiosurgery ® platform.

Catalent, Inc. today announced financial results for the fourth quarter of fiscal 2022, which ended June 30, 2022.

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into a license agreement relating to its preclinical asset, Nepicastat, with Asieris Pharmaceuticals, a biotechnology company headquartered in China.

Moderna, Inc today announced it will host its in-person and virtual R&D Day at 9:00 a.m. ET on Thursday, September 8, 2022.